GGrantIndex
← Leaderboards

Gerald T. Cochran

Utah State Higher Education System--University Of Utah

Google Scholar ↗PubMed ↗ORCID ↗
$15,834,474
Attributed
$23,716,802
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.1M · FY2012–25
$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,575,192 · 4
CDC$3,098,712 · 3
AHRQ$42,898 · 1

By mechanism

UG1$15,961,569 · 1
R01$5,512,796 · 2
U01$1,099,895 · 2
R34$708,250 · 1
R21$391,394 · 1
R36$42,898 · 1

Top collaborators

Most similar at Utah State Higher Education System--University Of Utah

Same institution · by research overlap

Others in their field

Top investigators on “Opioid”

Research focus

OpioidPharmaceutical PreparationsCommunity PharmacyPharmacy FacilityOpioid Use DisorderPrescription Opioid MisuseOverdoseAddictionCommunitiesReportingOpioid EpidemicPrescription OpioidNational Institute Of Drug AbusePreventCaringUtahInsightBehaviorResourcesAmericanOpiate AddictionDrug PrescriptionsResponseTraining

Grant awards (28)

Greater Intermountain Node (CTN-0138)$1,761,246
UG1 · FY2025 · DA · contact PI
Greater Intermountain Node$791,074
UG1 · FY2025 · DA
Randomized Trial: Optimizing Pregnancy and Treatment Interventions for Moms (OPTI-Mom) 3.0$700,000
U01 · FY2025 · CE · contact PI
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial$600,020
R01 · FY2025 · DA · contact PI
Greater Intermountain Node (CTN-0151)$243,811
UG1 · FY2025 · DA · contact PI
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial$717,674
R01 · FY2024 · DA · contact PI
Co-Use of Opioid Medications and Alcohol Prevention Study (COAPS)$227,679
R34 · FY2024 · AA · contact PI
Greater Intermountain Node$2,359,488
UG1 · FY2023 · DA
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial$722,123
R01 · FY2023 · DA · contact PI
Co-Use of Opioid Medications and Alcohol Prevention Study (COAPS)$232,819
R34 · FY2023 · AA · contact PI
Adaptation and Implementation of a Community Pharmacy-Based Prescription Drug Monitoring Pro-gram Opioid Risk Assessment Tool$2,330,942
UG1 · FY2022 · DA
Greater Intermountain Node$1,478,733
UG1 · FY2022 · DA
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial$726,896
R01 · FY2022 · DA · contact PI
Greater Intermountain Node$336,995
UG1 · FY2022 · DA
Co-Use of Opioid Medications and Alcohol Prevention Study (COAPS)$247,752
R34 · FY2022 · AA · contact PI
Greater Intermountain Node$1,293,444
UG1 · FY2021 · DA
Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial$747,266
R01 · FY2021 · DA · contact PI
Greater Intermountain Node$1,553,336
UG1 · FY2020 · DA
Optimizing Pregnancy and Treatment Interventions for Moms 2.0$602,979
R01 · FY2020 · CE · contact PI
Greater Intermountain Node$3,812,500
UG1 · FY2019 · DA
Optimizing Pregnancy and Treatment Interventions for Moms 2.0$688,258
R01 · FY2019 · CE · contact PI
Optimizing Pregnancy and Treatment Interventions for Moms 2.0$707,580
R01 · FY2018 · CE · contact PI
Prescription opioid misuse: Pharmacist-delivered intervention at point of service$135,148
R21 · FY2018 · DA · contact PI
Prescription opioid misuse: Pharmacist-delivered intervention at point of service$24,895
R21 · FY2018 · DA · contact PI
Prescription opioid misuse: Pharmacist-delivered intervention at point of service$231,351
R21 · FY2017 · DA · contact PI
The Influence of Formulary Management Strategies on Opioid Medication Use.$199,946
U01 · FY2015 · CE · contact PI
The Influence of Formulary Management Strategies on Opioid Medication Use.$199,949
U01 · FY2014 · CE · contact PI
Latent Classes and Transitions for Brief Alcohol Interventions in Trauma Settings$42,898
R36 · FY2012 · HS · contact PI